IJE Software logoIJEsoft
ServicesPortfolioPricingAboutCase StudyStackNewsBlogPartnerPH NewsMarketsContactGet in touch
← Back to Philippines Business News
Manila Times Business

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recognised as the largest modifiable risk factor for dementia. Yet whether hearing aids can reduce dementia risk remains debated. To explore this, researchers from University Hospital Zurich and the University

Context & Analysis

The aging Filipino workforce and rising chronic disease burden are quietly reshaping healthcare demand across the Philippines. As life expectancy climbs and corporate leaders face mounting pressure to sustain employee productivity, conditions that impair cognitive function are moving from clinical concerns to operational priorities. Hearing impairment, often overlooked in workplace health assessments, intersects directly with long-term cognitive decline, making audiology interventions a strategic consideration for employers and insurers alike.

For Philippine businesses, the practical implication lies in preventive health investment. Companies that integrate routine sensory screenings into occupational health programs may reduce long-term disability costs and preserve skilled labor retention. Insurance providers designing senior-focused or comprehensive wellness products will need to evaluate whether audiology coverage yields measurable returns in delayed cognitive deterioration. The Food and Drug Administration of the Philippines already regulates hearing devices as medical equipment, but market access remains uneven, with imported units often priced beyond middle-income reach. This gap presents an opportunity for local distributors and healthtech firms to develop tiered financing models aligned with corporate wellness budgets.

Investors should monitor how Philippine-listed healthcare and insurance groups adjust their product portfolios as clinical evidence on sensory interventions strengthens. Any shift toward covering hearing aids under group health plans or PhilHealth benefits could unlock a fragmented domestic market currently dominated by cash transactions. Multinational audiology brands may also accelerate partnerships with local clinics to navigate regulatory clearance and distribution bottlenecks.

What to watch next includes FDA Philippines updates on device classification, corporate wellness spending trends, and whether PhilHealth revises its benefit package to include preventive audiology. As cognitive health becomes a measurable component of workforce resilience, businesses that treat hearing preservation as infrastructure rather than an afterthought will likely gain an edge in talent retention and long-term risk management.

Analysis by IJE Software — original commentary on the story above.

This is an excerpt. Read the full article at the original source:

Source: manilatimes.net

More from Manila Times Business

Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme

7h ago

Disclosure of transactions on shares from August 17, 2026, to August 21, 2026

7h ago

Melexis: update on the share buy-back program

7h ago

ASM share buyback update August 17 - 21, 2026

7h ago

Your Daily Briefing

AI business companion — delivered every morning

Markets, PH news, financial insights, and devotionals — curated by AI and sent at 7 AM PHT. Pick your topics below.

Devotionals
Blog Topics
HR & Workforce
Real Estate & Property
News & Markets

1 topic selected